Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Greil

Showing results (241-250 of 483) with videos related to

Pageof 49
Sort By:
Medicine|May 9, 2020
Comparison of high tone therapy and transcutaneous electrical nerve stimulation therapy in chemotherapy-induced polyneuropathyDagmar Schaffler-Schaden, Robert Sassmann, Tim Johansson, et al.
European Journal of Cancer (Oxford, England : 1990)|May 22, 2021
Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trialFelix Keil, Maximilian Hartl, Gabriela Altorjai, et al.
Clinical Colorectal Cancer|February 19, 2008
Oxaliplatin in combination with 5-fluorouracil/leucovorin or capecitabine in elderly patients with metastatic colorectal cancerHendrik-Tobias Arkenau, Ullrich Graeven, Stephan Kubicka, et al.
Breast Cancer Research and Treatment|December 18, 2007
The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07)Susanne Taucher, Guenther G Steger, Raimund Jakesz, et al.
Blood Advances|August 10, 2022
Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01/2010 studyOlga Oleshko, Sonja Werwitzke, Annika Klingberg, et al.
Acta Oncologica (Stockholm, Sweden)|April 19, 2011
Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trialsSilvia Hofer, Katarzyna Elandt, Richard Greil, et al.
Cancers|February 10, 2021
Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous BiopsiesTeresa Magnes, Sandro Wagner, Aaron R Thorner, et al.
British Journal of Cancer|October 21, 2016
Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancerMeinolf Karthaus, Ralf-Dieter Hofheinz, Laurent Mineur, et al.
Cancer Medicine|November 12, 2018
Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trialTheresa Westphal, Gabriel Rinnerthaler, Simon Peter Gampenrieder, et al.
Therapeutic Advances in Medical Oncology|October 25, 2021
Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6)Gabriel Rinnerthaler, Simon Peter Gampenrieder, Andreas Petzer, et al.
Pageof 49

Showing results (241-250 of 483) with videos related to

Sort By:
Pageof 49
Medicine|May 9, 2020
Comparison of high tone therapy and transcutaneous electrical nerve stimulation therapy in chemotherapy-induced polyneuropathyDagmar Schaffler-Schaden, Robert Sassmann, Tim Johansson, et al.
European Journal of Cancer (Oxford, England : 1990)|May 22, 2021
Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trialFelix Keil, Maximilian Hartl, Gabriela Altorjai, et al.
Clinical Colorectal Cancer|February 19, 2008
Oxaliplatin in combination with 5-fluorouracil/leucovorin or capecitabine in elderly patients with metastatic colorectal cancerHendrik-Tobias Arkenau, Ullrich Graeven, Stephan Kubicka, et al.
Breast Cancer Research and Treatment|December 18, 2007
The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07)Susanne Taucher, Guenther G Steger, Raimund Jakesz, et al.
Blood Advances|August 10, 2022
Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01/2010 studyOlga Oleshko, Sonja Werwitzke, Annika Klingberg, et al.
Acta Oncologica (Stockholm, Sweden)|April 19, 2011
Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trialsSilvia Hofer, Katarzyna Elandt, Richard Greil, et al.
Cancers|February 10, 2021
Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous BiopsiesTeresa Magnes, Sandro Wagner, Aaron R Thorner, et al.
British Journal of Cancer|October 21, 2016
Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancerMeinolf Karthaus, Ralf-Dieter Hofheinz, Laurent Mineur, et al.
Cancer Medicine|November 12, 2018
Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trialTheresa Westphal, Gabriel Rinnerthaler, Simon Peter Gampenrieder, et al.
Therapeutic Advances in Medical Oncology|October 25, 2021
Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6)Gabriel Rinnerthaler, Simon Peter Gampenrieder, Andreas Petzer, et al.
Pageof 49